Search for Clinical Trial Results

Sponsored By

Acute Graft Versus Host Disease - 162 Studies Found

Status Study
Completed Study Name: The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Date: 2005-08-30
Interventions: Drug: Etanercept Patients enrolled on the study will receive etanercept at 0.4 mg/kg per dose up to a ma
Suspended Study Name: Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD
Condition:
  • Chronic Graft vs. Host Disease
  • Graft vs Host Disease
  • Graft
    Date: 2014-12-20
    Interventions:
    • Procedure: Extracorporeal Photopheresis (ECP)

Completed Study Name: ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis
Condition:
  • Hematopoietic Stem Cell Transplantation
  • Antithymocyte Globulin
  • Cancer
  • Graft-Versus-Host Disease

Date: 2008-12-10
Interventions:
  • Drug: MEDI-507 0.12 mg/kg of M
Completed Study Name: Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Date: 2013-02-18
Interventions: Biological: Cultured Treg cells Co-culturing of recipient dendritic cells and donor Treg. Treg administr
Completed Study Name: Photopheresis for the Treatment of Acute Graft Versus Host Disease
Condition: Graft Versus Host Disease
Date: 2008-01-23
Interventions:
  • Procedure: Photopheresis 8-9 p
Completed Study Name: Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation
Condition: Hematological Malignancies
Date: 2016-07-04
Interventions: Biological: Allogeneic MPBC transplantation from matched related donor
Not yet recruiting Study Name: Modification of the Intestinal Microbiome by Diet Intervention to Mitigate Acute Graft-Versus-Host Disease
Condition: Hematopoietic Stem Cell Transplantation
Date: 2016-05-03
Interventions:
  • Dietary Supplement: Bob's Red Mill®
  • O
Not yet recruiting Study Name: Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2010-01-07
    Interventions:
    • Drug: rituximab Given IV
Suspended Study Name: T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Condition:
  • Breast Cancer
  • Chronic Myeloproliferative Disorders
  • Gestati
    Date: 2008-04-02
    Interventions:
    • Other: flow cytometry Lymphocy
<<< Previous | Next >>>